Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A6 | Q4U2R8 | 2/20 | 0.69 |
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.67 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.67 |
| ▸ | SLC13A3 | Q8WWT9 | 1/20 | 0.67 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.67 |
| ▸ | LMNA | P02545 | 4/20 | 0.59 |
| ▸ | TSHR | P16473 | 4/20 | 0.56 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.56 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.56 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.50 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.48 |
| ▸ | GABRR3 | A8MPY1 | 1/20 | 0.48 |
| ▸ | GABRP | O00591 | 1/20 | 0.48 |
| ▸ | GABRD | O14764 | 1/20 | 0.48 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.48 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | THRB | P10828 | 1/20 | 0.48 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.48 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL715450 | 0.97 | SLC22A6 (0.65) | SLC22A6EGLN1MAPK1SLC13A3OR51E2 | |
| Alpha-Ketoglutaric Acid SCHEMBL27892915 | 0.94 | EGLN1 (0.78) | SLC22A6EGLN1MAPK1SLC13A3OR51E2 | |
| SCHEMBL259198 | 0.94 | LMNA (0.69) | SLC22A6EGLN1MAPK1SLC13A3OR51E2 | |
| SCHEMBL14357994 | 0.94 | LMNA (0.69) | SLC22A6EGLN1MAPK1SLC13A3OR51E2 | |
| Urea SCHEMBL29106847 | 0.92 | SLC22A6 (0.58) | SLC22A6EGLN1MAPK1SLC13A3OR51E2 | |
| SCHEMBL2993356 | 0.91 | TSHR (0.71) | SLC22A6EGLN1MAPK1SLC13A3OR51E2 | |
| SCHEMBL9794734 | 0.91 | TSHR (0.71) | SLC22A6EGLN1MAPK1SLC13A3OR51E2 | |
| SCHEMBL20537125 | 0.91 | TSHR (0.71) | SLC22A6EGLN1MAPK1SLC13A3OR51E2 | |
| SCHEMBL15052528 | 0.91 | LMNA (0.65) | SLC22A6EGLN1MAPK1SLC13A3OR51E2 | |
| SCHEMBL2780784 | 0.91 | TSHR (0.71) | SLC22A6EGLN1MAPK1SLC13A3OR51E2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1435 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747627-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | Matterworks Inc (US) | 2026-05-27 | — | — | EP | claimed |
| EP-3869192-B1 | METHOD FOR QUANTITATIVE DETECTION OF VARIOUS METABOLITES IN BIOLOGICAL SAMPLE | HUMAN METABOLOMICS INST INC (CN) | 2026-05-13 | — | — | EP | claimed |
| US-12566228-B2 | Temperature cycling method for hyperpolarization of target molecules and contrast agents using parahydrogen | NORTH CAROLINA STATE UNIVERSITY (US) | 2026-03-03 | — | — | US | claimed |
| US-20260048155-A1 | BIOCOMPATIBLE PARAHYDROGEN HYPERPOLARIZED SOLUTIONS BY PRECIPITATION AND RE-DISSOLUTION | UNIV NORTH CAROLINA STATE (US) | 2026-02-19 | — | — | US | claimed |
| EP-4679086-A1 | BIOMARKER AND USE THEREOF | MEIJI CO., LTD (JP) | 2026-01-14 | — | — | EP | claimed |
| US-12435294-B2 | Prevention of the oxidation of perfumery raw materials and food raw materials | FIRMENICH SA (CH) | 2025-10-07 | — | — | US | claimed |
| US-20250271524-A1 | METHODS FOR PROTON-ONLY DETECTION OF HYPERPOLARIZED HETERONUCLEAR SINGLET STATES | WAYNE STATE UNIVERSITY | 2025-08-28 | — | — | US | claimed |
| US-20250258146-A1 | QUANTITATIVE DETECTION METHOD OF MULTIPLE METABOLITES IN BIOLOGICAL SAMPLE AND METABOLIC CHIP | HUMAN METABOLOMICS INSTITUTE INC. (CN) | 2025-08-14 | — | — | US | claimed |
| EP-4544061-A1 | MICROORGANISMS AND METHODS FOR THE CONTINUOUS CO-PRODUCTION OF TANDEM REPEAT PROTEINS AND CHEMICAL PRODUCTS FROM C1-SUBSTRATES | Lanzatech, Inc. (US) | 2025-04-30 | — | — | EP | claimed |
| EP-4544062-A1 | MICROORGANISMS AND METHODS FOR THE CONTINUOUS CO-PRODUCTION OF HIGH-VALUE, SPECIALIZED PROTEINS AND CHEMICAL PRODUCTS FROM C1-SUBSTRATES | Lanzatech, Inc. (US) | 2025-04-30 | — | — | EP | claimed |
| WO-2005052575-A1 | MOLECULAR MARKERS OF OXIDATIVE STRESS | PFIZER LIMITED (GB) | 2005-06-09 | — | — | WO | claimed |
| EP-1524989-A2 | METHOD AND COMPOSITION FOR PROTECTING NEURONAL TISSUE FROM DAMAGE INDUCED BY ELEVATED GLUTAMATE LEVELS | YEDA RESEARCH AND DEVELOPMENT Co. LTD. (IL) | 2005-04-27 | — | — | EP | claimed |
| WO-2004012762-A2 | METHOD AND COMPOSITION FOR PROTECTING NEURONAL TISSUE FROM DAMAGE INDUCED BY ELEVATED GLUTAMATE LEVELS | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2004-02-12 | — | — | WO | claimed |
| EP-1041154-B1 | Process for the preparation of 5-aminolevulinic acid | COSMO RES INST (JP) | 2003-03-12 | — | — | EP | claimed |
| US-20020155192-A1 | Yeast transport isoforms | MEDICAL RESEARCH COUNCIL (GB) | 2002-10-24 | — | — | US | claimed |
| WO-2002010395-A1 | ISOFORMS OF AN OXODICARBOXYLATES TRANSPORTER OF S. CEREVISIAE | MEDICAL RESEARCH COUNCIL (GB) | 2002-02-07 | — | — | WO | claimed |
| EP-1041154-A1 | 5-Aminolevulinic acid producing microorganism and process for producing 5-aminolevulinic acid | COSMO RESEARCH INSTITUTE (JP) | 2000-10-04 | — | — | EP | claimed |
| US-5763235-A | PHOTOSYNTHETIC BACTERIUM WHICH PRODUCES 5-AMINOLEVULINIC ACID WITHOUT LIGHT IRRADIATION | COSMO RESEARCH INSTITUTE (JP) | 1998-06-09 | — | — | US | claimed |
| EP-0718405-A2 | 5-Aminolevulinic acid producing microorganism, and process for producing it | COSMO RESEARCH INSTITUTE (JP) | 1996-06-26 | — | — | EP | claimed |
| US-4931509-A | EPOXY-CONTAINING MONOMER; EXCELLENT VULCANIZING WITH UREAS, QUATERNARY AMMONIUM AND PHOSPHONIUM SALTS AND POLYCARBOXYLIC ACIDS OR ANHYDRIDES | NIPPON ZEON CO., LTD. (JP) | 1990-06-05 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260048155-A1 | BIOCOMPATIBLE PARAHYDROGEN HYPERPOLARIZED SOLUTIONS BY PRECIPITATION AND RE-DISSOLUTION | HNRNPR, SIGMAR1, MAP2K1 | SLC22A6 1086/4885EGLN1 1749/4885MAPK1 200/4885 |
| US-12435294-B2 | Prevention of the oxidation of perfumery raw materials and food raw materials | CUTA, MPO, GPX4 | SLC22A6 3941/4885EGLN1 1050/4885MAPK1 2336/4885 |
| US-12566228-B2 | Temperature cycling method for hyperpolarization of target molecules and contrast agents using parahydrogen | PDK1, MPC2, PC | SLC22A6 689/4885EGLN1 382/4885MAPK1 738/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.